Novavax Inc
NVAX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001000694
No open-market purchases or sales by Novavax Inc insiders were filed in the last 90 days; 267 institutions reported holding it in 13F filings for Q2 2026, worth $1.11B in total; Coatue Management is the only superinvestor holding it.
Members of Congress who traded NVAX
Since 2020, newest trade first. Options and trades reported under an earlier ticker are included.
- Trades
- 2
- Filings
- 2
- Members
- 1
- Buys / sells
- 1 / 1
- Estimated volume
- $16.0K
- Sum of range midpoints
| Member | Trades | Buys / sells | Est. volume | Last traded | Last filed |
|---|---|---|---|---|---|
| Pat RobertsRepublican · Senate · KS | 2 | 1 / 1 | $16.0K | Oct 13, 2020 | Nov 5, 2020 |
Trades
Every reported trade in Novavax Inc, newest filings first.
| Member | Asset | Type | Owner | Traded | Filed | Delay | Amount | Source |
|---|---|---|---|---|---|---|---|---|
| Pat RobertsRepublican · Senate · KS | NVAXNovavax, Inc. | Sell (full) | Spouse | Oct 13, 2020 | Nov 5, 2020 | 23 days | $1K-$15K | Filing |
| Pat RobertsRepublican · Senate · KS | NVAXNovavax, Inc. | Buy | Spouse | Aug 17, 2020 | Aug 30, 2020 | 13 days | $1K-$15K | Filing |
Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.